TNF-α |
Forward: 5′-TAGCCCATGTTGTAGCAAACC-3′; Reverse: 5′-ATGAGGTACAGGCCCTCTGAT-3′ |
CCL3 |
Forward: 5′-GCTGACTACTTTGAGACGAGCA-3′; Reverse: 5′-ATATTTCTGGACCCACTCCTCA-3′ |
AMAC-1 |
Forward: 5′- GCTGCCTCGTCTATACCTCCT-3′; Reverse: 5′-GGTCGCTGATGTATTTCTGGA-3′ |
CCL18 |
Forward: 5′-TACCTCCTGGCAGATTCCAC-3′; Reverse: 5′-CCCACTTCTTATTGGGGTCA-3′ |
CCL22 |
Forward: 5′-TGATTACGATCCGTTACCGTCT-3′; Reverse: 5′-CCTGAAGGTTAGCAACACCAC -3′ |
Arg-1 |
Forward: 5′- CCCTTTGCTGACATCCCTAAT-3′; Reverse: 5′-GGCTGATTCTTCCGTTCTTCT-3′ |
E-cadherin |
Forward :5′-GAATGACAACAAGCCCGAAT-3′; Reverse:5′-GACCTCCATCACAGAGGTTCC-3′ |
N-cadherin |
Fo rward :5′-GGTGGAGGAGAAGAAGACCAG-3′ ; Reverse:5′-GCATCAGGCTCCACAGT-3′ |
Vimentin |
Forward: 5′-TCCGCACATTCGAGCAAAGA-3′; Reverse: 5′-TGAGGGCTCCTAGCGGTTTA-3′ |
a-SMA |
Forward: 5′-CTTGTCCAGGAGTTCCGCTC-3′; Reverse: 5′- TTTCTTGGGCCTTGATGCGA-3′ |
β-actin |
Forward: 5′-CATGTACGTTGCTATCCAGGC -3′; Reverse: 5′- CTCCTTAATGTCACGCACGAT-3′ |